Last $15.46 USD
Change Today -0.50 / -3.13%
Volume 450.3K
INSM On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

insmed inc (INSM) Snapshot

Open
$15.97
Previous Close
$15.96
Day High
$16.43
Day Low
$15.31
52 Week High
02/27/14 - $21.15
52 Week Low
08/12/14 - $11.25
Market Cap
767.8M
Average Volume 10 Days
431.1K
EPS TTM
$-1.90
Shares Outstanding
49.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSMED INC (INSM)

insmed inc (INSM) Related Bloomberg News

View More Bloomberg News

insmed inc (INSM) Related Businessweek News

No Related Businessweek News Found

insmed inc (INSM) Details

Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers a proven and potent anti-infective directly to the site of serious lung infections. The company’s ARIKAYCE is in Phase II clinical trial for patients with lung infections caused by non-tuberculous mycobacteria (NTM) in the United States and Canada; and completed a Phase III clinical trial in Europe and Canada for cystic fibrosis (CF) patients who have lung infections caused by Pseudomonas aeruginosa. Insmed Incorporated was founded in 1999 and is headquartered in Bridgewater, New Jersey.

61 Employees
Last Reported Date: 03/6/14
Founded in 1999

insmed inc (INSM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $445.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $330.0K
General Counsel and Corporate Secretary
Total Annual Compensation: $149.9K
Special Advisor To Chief Executive Officer
Total Annual Compensation: $422.2K
Compensation as of Fiscal Year 2013.

insmed inc (INSM) Key Developments

Insmed Incorporated Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 09:00 AM

Insmed Incorporated Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 09:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Anne Marie Fields, Senior Vice President, William H. Lewis, Chief Executive Officer, President and Director.

Insmed Incorporated Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Insmed Incorporated Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Insmed Incorporated(NasdaqGS:INSM) added to NASDAQ Biotechnology Index

Insmed Incorporated will be added to the NASDAQ Biotechnology Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INSM:US $15.46 USD -0.50

INSM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INSM.
View Industry Companies
 

Industry Analysis

INSM

Industry Average

Valuation INSM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSMED INC, please visit www.insmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.